{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:55:12Z","timestamp":1788292512995,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovation Fund","doi-asserted-by":"publisher","award":["VACOP 8089-00019B"],"award-info":[{"award-number":["VACOP 8089-00019B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jvacx.2024.100548","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T07:12:26Z","timestamp":1723792346000},"page":"100548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comparison of measles plaque reduction neutralization test (PRNT) and measles virus-specific IgG ELISA for assessment of immunogenicity of measles-mumps-rubella vaccination at 5\u20137\u00a0months of age and maternal measles antibodies"],"prefix":"10.1016","volume":"20","author":[{"given":"Dorthe Maria","family":"Vittrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-2982","authenticated-orcid":false,"given":"Andreas","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2436-4293","authenticated-orcid":false,"given":"Michelle","family":"Malon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Cathrine","family":"Zimakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Kiehn S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brickley","family":"Littell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-2723","authenticated-orcid":false,"given":"Eric A.F.","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9365-0728","authenticated-orcid":false,"given":"Jannet","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Graff Stensballe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100548_b0005","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1371\/journal.pmed.0020316","article-title":"A Measles Epidemic Threshold in a Highly Vaccinated Population","volume":"2","author":"Wallinga","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.jvacx.2024.100548_b0010","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R0) of measles: a systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100548_b0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12879-023-08199-8","article-title":"Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT","volume":"23","author":"Lutz","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100548_b0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ije\/dyn224","article-title":"Estimates of measles case fatality ratios: a comprehensive review of community-based studies","volume":"38","author":"Wolfson","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jvacx.2024.100548_b0025","unstructured":"Measles vaccines: WHO position paper, April 2017 \u2013 Recommendations - ScienceDirect. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0264410X1730974X?via%3Dihub (accessed Sept 8, 2023)."},{"key":"10.1016\/j.jvacx.2024.100548_b0030","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1473-3099(19)30395-0","article-title":"Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis","volume":"19","author":"Nic Lochlainn","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100548_b0035","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.15585\/mmwr.mm7246a3","article-title":"Progress toward measles elimination - worldwide, 2000\u20132022","volume":"72","author":"Minta","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jvacx.2024.100548_b0040","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2008.08.074","article-title":"Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination","volume":"26","author":"Cohen","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100548_b0045","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100548_b0050","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/infdis\/jiz380","article-title":"What is the evidence to support a correlate of protection for measles? a systematic review","volume":"221","author":"Bolotin","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100548_b0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100548_b0060","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1186\/s13063-020-04845-7","article-title":"Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial","volume":"21","author":"Vittrup","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jvacx.2024.100548_b0065","doi-asserted-by":"crossref","unstructured":"Vittrup DM, Jensen A, S\u00f8rensen JK, et al. Immunogenicity and reactogenicity following MMR vaccination in 5\u20137-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infants. eClinicalMedicine 2024; 68. DOI:10.1016\/j.eclinm.2023.102421.","DOI":"10.1016\/j.eclinm.2023.102421"},{"key":"10.1016\/j.jvacx.2024.100548_b0070","unstructured":"The Danish Serum Institute. Overv\u00e5gning i tal, grafer og kort. https:\/\/statistik.ssi.dk\/\/sygdomsdata#!\/?sygdomskode=MEAS&xaxis=Aar&show=Graph&datatype=Individual (accessed Jan 30, 2024)."},{"key":"10.1016\/j.jvacx.2024.100548_b0075","unstructured":"Creative Diagnostics. Antibodies, Antigens, Elisa Kits for Life Science - Creative Diagnostics. Website for Creative Diagnostics. https:\/\/www.creative-diagnostics.com\/ (accessed Feb 21, 2023)."},{"key":"10.1016\/j.jvacx.2024.100548_b0080","unstructured":"WHO, NIBSC. WHO International Standard 3rd International Standard for Anti-Measles NIBSC code: 97\/648. https:\/\/www.nibsc.org\/documents\/ifu\/97-648.pdf (accessed Dec 20, 2022)."},{"key":"10.1016\/j.jvacx.2024.100548_b0085","first-page":"62","article-title":"The Immunological Basis of Immunization Series Module 7","author":"Moss","year":"2009","journal-title":"Measles"},{"key":"10.1016\/j.jvacx.2024.100548_b0090","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation Coefficients: Appropriate Use and Interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jvacx.2024.100548_b0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: Comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jvacx.2024.100548_b0100","unstructured":"The Danish Serum Institute. Statens Serum Institut, M\u00e6slinger. https:\/\/www.ssi.dk\/vaccinationer\/boernevaccination\/vaccination-mod-maeslinger (accessed Oct 3, 2023)."},{"key":"10.1016\/j.jvacx.2024.100548_b0105","article-title":"Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay","volume":"12","author":"Hamkar","year":"2006","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.jvacx.2024.100548_b0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/vim.2017.0143","article-title":"Measles vaccine","volume":"31","author":"Griffin","year":"2018","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jvacx.2024.100548_b0115","first-page":"119","article-title":"Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin g avidity in measles cases during the 1997 S\u00e3o Paulo epidemic","volume":"11","author":"Pannuti","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jvacx.2024.100548_b0120","doi-asserted-by":"crossref","first-page":"e00265","DOI":"10.1128\/JCM.00265-20","article-title":"Qualitative Variation among Commercial Immunoassays for Detection of Measles-Specific IgG","volume":"58","author":"Latner","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jvacx.2024.100548_b0125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/infdis\/jis719","article-title":"Measles humoral and cell-mediated immunity in children aged 5\u201310 Years after primary measles immunization administered at 6 or 9 months of age","volume":"207","author":"Gans","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100548_b0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2020.08.002","article-title":"Measles immunity and immunosuppression","volume":"46","author":"Griffin","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jvacx.2024.100548_b0135","first-page":"19","article-title":"Effect of multiple freeze-thaw cycles on detection of measles, mumps, and rubella virus antibodies","volume":"10","author":"Pinsky","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jvacx.2024.100548_b0140","unstructured":"The Danish Serum Institute. Danmark har elimineret m\u00e6slinger. https:\/\/www.ssi.dk\/aktuelt\/nyheder\/2017\/2017-9-epinyt-37-maeslinger (accessed Oct 6, 2023)."},{"key":"10.1016\/j.jvacx.2024.100548_b0145","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jiz159","article-title":"Early Measles Vaccination During an Outbreak in the Netherlands: Short-Term and Long-Term Decreases in Antibody Responses Among Children Vaccinated Before 12 Months of Age","volume":"220","author":"Brinkman","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100548_b0150","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1080\/21645515.2019.1619402","article-title":"Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study","volume":"15","author":"Bolotin","year":"2019","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224001219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T19:29:24Z","timestamp":1729020564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224001219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":30,"alternative-id":["S2590136224001219"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100548","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of measles plaque reduction neutralization test (PRNT) and measles virus-specific IgG ELISA for assessment of immunogenicity of measles-mumps-rubella vaccination at 5\u20137\u00a0months of age and maternal measles antibodies","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100548"}}